BowTiedBiotech

BowTiedBiotech

Share this post

BowTiedBiotech
BowTiedBiotech
Epoch 24: Regulatory & Macro Concerns Persist

Epoch 24: Regulatory & Macro Concerns Persist

Macro, IRA, Drug Pricing

BowTiedBiotech's avatar
BowTiedBiotech
Jun 15, 2023
∙ Paid
1

Share this post

BowTiedBiotech
BowTiedBiotech
Epoch 24: Regulatory & Macro Concerns Persist
1
Share

Welcome to the 10 NEW Biotech Innovators who have joined us this month! If you haven’t subscribed, join the 1,189 researchers, investors, operators, academics, clinicians and entrepreneurs by subscribing here:

Hello Avatar!  Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update.  The…

Keep reading with a 7-day free trial

Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 BowTiedBiotech
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share